- Home
- CASH vs IRON Comparison
CASH vs IRON Comparison
Compare CASH & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CASH
- IRON
- Stock Information
- Founded
- CASH 1954
- IRON 2017
- Country
- CASH United States
- IRON United States
- Employees
- CASH N/A
- IRON N/A
- Industry
- CASH Major Banks
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- CASH Finance
- IRON Health Care
- Exchange
- CASH Nasdaq
- IRON Nasdaq
- Market Cap
- CASH 1.8B
- IRON 1.8B
- IPO Year
- CASH N/A
- IRON N/A
- Fundamental
- Price
- CASH $81.52
- IRON $51.38
- Analyst Decision
- CASH Buy
- IRON Strong Buy
- Analyst Count
- CASH 2
- IRON 10
- Target Price
- CASH $92.00
- IRON $93.40
- AVG Volume (30 Days)
- CASH 179.1K
- IRON 411.3K
- Earning Date
- CASH 07-23-2025
- IRON 08-07-2025
- Dividend Yield
- CASH 0.25%
- IRON N/A
- EPS Growth
- CASH 10.71
- IRON N/A
- EPS
- CASH 7.36
- IRON N/A
- Revenue
- CASH $731,383,000.00
- IRON N/A
- Revenue This Year
- CASH $13.95
- IRON N/A
- Revenue Next Year
- CASH $5.74
- IRON N/A
- P/E Ratio
- CASH $10.75
- IRON N/A
- Revenue Growth
- CASH 6.51
- IRON N/A
- 52 Week Low
- CASH $56.30
- IRON $30.82
- 52 Week High
- CASH $86.00
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- CASH 56.54
- IRON 56.63
- Support Level
- CASH $75.82
- IRON $52.52
- Resistance Level
- CASH $80.68
- IRON $55.52
- Average True Range (ATR)
- CASH 1.52
- IRON 2.39
- MACD
- CASH 0.56
- IRON 0.03
- Stochastic Oscillator
- CASH 76.16
- IRON 61.58
About CASH Pathward Financial Inc.
Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.